122 related articles for article (PubMed ID: 12097462)
21. [Nuclear oncology update].
Maublant J; Resche I; Giammarile F; Corone C; Artus JC
Bull Cancer; 1999 Jan; 86(1):57-64. PubMed ID: 10029706
[No Abstract] [Full Text] [Related]
22. Breast-specific gamma imaging as an adjunct imaging modality for the diagnosis of breast cancer.
Brem RF; Floerke AC; Rapelyea JA; Teal C; Kelly T; Mathur V
Radiology; 2008 Jun; 247(3):651-7. PubMed ID: 18487533
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic accuracy of 99mTc-sestamibi breast imaging: multicenter trial results.
Khalkhali I; Villanueva-Meyer J; Edell SL; Connolly JL; Schnitt SJ; Baum JK; Houlihan MJ; Jenkins RM; Haber SB
J Nucl Med; 2000 Dec; 41(12):1973-9. PubMed ID: 11138681
[TBL] [Abstract][Full Text] [Related]
24. Breast-specific gamma-imaging: molecular imaging of the breast using 99mTc-sestamibi and a small-field-of-view gamma-camera.
Jones EA; Phan TD; Blanchard DA; Miley A
J Nucl Med Technol; 2009 Dec; 37(4):201-5. PubMed ID: 19914975
[TBL] [Abstract][Full Text] [Related]
25. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW
Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
[TBL] [Abstract][Full Text] [Related]
26. The role of technetium-99m methoxyisobutylisonitrile scintimammography in diagnosis of breast cancer in patients with mammographically dense breasts.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH
Anticancer Res; 2000; 20(5C):3755-8. PubMed ID: 11268450
[TBL] [Abstract][Full Text] [Related]
27. Role of Tc-99m tetrofosmin imaging in the examination of patients with breast lesions.
Schillaci O; Danieli R; Scopinaro F
Radiology; 1999 Jan; 210(1):284-6. PubMed ID: 9885623
[No Abstract] [Full Text] [Related]
28. MBI: M(I)BI agonistes or a new chapter?
Brenner RJ
Breast J; 2007; 13(1):1-2. PubMed ID: 17214786
[No Abstract] [Full Text] [Related]
29. Tc-99m sestamibi scintimammography: where is it now?
Schillaci O; Scopinaro F
Cancer Biother Radiopharm; 1999 Dec; 14(6):417-22. PubMed ID: 10850328
[No Abstract] [Full Text] [Related]
30. Sestamibi scanning of breast cancer.
Shaffer P
J Nucl Med; 2002 Jan; 43(1):125-6. PubMed ID: 11801715
[No Abstract] [Full Text] [Related]
31. Significant breast uptake of Tc-99m sestamibi in an actively lactating woman during SPECT myocardial perfusion imaging.
Ramakrishna G; Miller TD
J Nucl Cardiol; 2004; 11(2):222-3. PubMed ID: 15052253
[No Abstract] [Full Text] [Related]
32. Updates in Molecular Breast Imaging.
Hruska CB
Semin Roentgenol; 2022 Apr; 57(2):134-138. PubMed ID: 35523526
[TBL] [Abstract][Full Text] [Related]
33. The SNM practice guideline on breast scintigraphy.
Goldsmith SJ
J Nucl Med; 2010 Dec; 51(12):1823-4. PubMed ID: 21098792
[No Abstract] [Full Text] [Related]
34. Diagnostic value of 99mTc-methylene diphosphonate and 99mTc-pentavalent DMSA compared with 99mTc-sestamibi for palpable breast lesions.
Massardo T; Alonso O; Kabasakal L; Llamas-Olier A; Shankar UR; Zhu H; Delgado L; González P; Mut F; Padhy AK
J Nucl Med; 2002 Jul; 43(7):882-8. PubMed ID: 12097457
[TBL] [Abstract][Full Text] [Related]
35. [++Scintimammography: a new imaging technique for diagnosis and follow-up of breast cancer].
Hermans J; Bodart F; François D; Merlo P; Fauconnier JP; Schmitz A; Gérard R; de Ruyver D; Eeckhoudt L
Bull Cancer; 2000 Apr; 87(4):334-40. PubMed ID: 10827352
[TBL] [Abstract][Full Text] [Related]
36. 99mTc-sestamibi imaging in the assessment of toremifene as a modulator of multidrug resistance in patients with breast cancer.
Mubashar M; Harrington KJ; Chaudhary KS; Lalani el-N; Stamp GW; Sinnett D; Glass DM; Peters AM
J Nucl Med; 2002 Apr; 43(4):519-25. PubMed ID: 11937596
[TBL] [Abstract][Full Text] [Related]
37. [99m Tc-MIBI scintigraphy compared to mammography in the diagnosis of breast cancer in dense, operated and young women breasts].
Mulero F; Nicolás F; Castellón MI; Fuentes T; de la Cruz P; Roca V; Abad L; Nuño de La Rosa JA
Rev Esp Med Nucl; 2000 Sep; 19(5):344-9. PubMed ID: 11062110
[TBL] [Abstract][Full Text] [Related]
38. Technetium-99m-sestamibi imaging in breast cancer: an alternative to thallium-201 imaging.
Aktolun C
J Nucl Med; 1994 Dec; 35(12):2055-6. PubMed ID: 7989994
[No Abstract] [Full Text] [Related]
39. What can we expect from MDR breast cancer imaging with sestamibi?
Palmedo H
J Nucl Med; 2002 Apr; 43(4):526-30. PubMed ID: 11937597
[No Abstract] [Full Text] [Related]
40. Prognostic value of (99m)Tc-sestamibi washout in predicting response of locally advanced breast cancer to neoadjuvant chemotherapy.
Sciuto R; Pasqualoni R; Bergomi S; Petrilli G; Vici P; Belli F; Botti C; Mottolese M; Maini CL
J Nucl Med; 2002 Jun; 43(6):745-51. PubMed ID: 12050317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
